These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18553123)

  • 21. Atelosteogenesis type 2.
    Newbury-Ecob R
    J Med Genet; 1998 Jan; 35(1):49-53. PubMed ID: 9475095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Undersulfation of cartilage proteoglycans ex vivo and increased contribution of amino acid sulfur to sulfation in vitro in McAlister dysplasia/atelosteogenesis type 2.
    Rossi A; Bonaventure J; Delezoide AL; Superti-Furga A; Cetta G
    Eur J Biochem; 1997 Sep; 248(3):741-7. PubMed ID: 9342225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production.
    Rossi A; Kaitila I; Wilcox WR; Rimoin DL; Steinmann B; Cetta G; Superti-Furga A
    Matrix Biol; 1998 Oct; 17(5):361-9. PubMed ID: 9822202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and molecular characterization of Diastrophic Dysplasia in the Portuguese population.
    Barbosa M; Sousa AB; Medeira A; Lourenço T; Saraiva J; Pinto-Basto J; Soares G; Fortuna AM; Superti-Furga A; Mittaz L; Reis-Lima M; Bonafé L
    Clin Genet; 2011 Dec; 80(6):550-7. PubMed ID: 21155763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SLC26A2 disease spectrum in Sweden - high frequency of recessive multiple epiphyseal dysplasia (rMED).
    Mäkitie O; Geiberger S; Horemuzova E; Hagenäs L; Moström E; Nordenskjöld M; Grigelioniene G; Nordgren A
    Clin Genet; 2015 Mar; 87(3):273-8. PubMed ID: 24598000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional analysis of diastrophic dysplasia sulfate transporter. Its involvement in growth regulation of chondrocytes mediated by sulfated proteoglycans.
    Satoh H; Susaki M; Shukunami C; Iyama K; Negoro T; Hiraki Y
    J Biol Chem; 1998 May; 273(20):12307-15. PubMed ID: 9575183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homozygosity for a novel DTDST mutation in a child with a 'broad bone-platyspondylic' variant of diastrophic dysplasia.
    Mégarbané A; Haddad FA; Haddad-Zebouni S; Achram M; Eich G; Le Merrer M; Superti-Furga A
    Clin Genet; 1999 Jul; 56(1):71-6. PubMed ID: 10466420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recessive multiple epiphyseal dysplasia (rMED) with homozygosity for C653S mutation in the DTDST gene--phenotype, molecular diagnosis and surgical treatment of habitual dislocation of multilayered patella: case report.
    Hinrichs T; Superti-Furga A; Scheiderer WD; Bonafé L; Brenner RE; Mattes T
    BMC Musculoskelet Disord; 2010 Jun; 11():110. PubMed ID: 20525296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multilayered patella: similar radiographic findings in pseudoachondroplasia and recessive multiple epiphyseal dysplasia.
    Vatanavicharn N; Lachman RS; Rimoin DL
    Am J Med Genet A; 2008 Jul; 146A(13):1682-6. PubMed ID: 18546327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MED resulting from recessively inherited mutations in the gene encoding calcium-activated nucleotidase CANT1.
    Balasubramanian K; Li B; Krakow D; Nevarez L; Ho PJ; Ainsworth JA; Nickerson DA; Bamshad MJ; Immken L; Lachman RS; Cohn DH
    Am J Med Genet A; 2017 Sep; 173(9):2415-2421. PubMed ID: 28742282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SLC26A2/DTDST Spectrum: A Cohort of 12 Patients Associated with a Comprehensive Review of the Genotype-Phenotype Correlation.
    Silveira C; da Costa Silveira K; Lacarrubba-Flores MD; Sakata MT; Carbognani SN; Llerena J; Moreno CA; Cavalcanti DP
    Mol Syndromol; 2023 Jan; 13(6):485-495. PubMed ID: 36660027
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Härkönen H; Loid P; Mäkitie O
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34064542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias.
    Rossi A; Cetta G; Piazza R; Bonaventure J; Steinmann B; Supereti-Furga A
    Pediatr Pathol Mol Med; 2003; 22(4):311-21. PubMed ID: 14692227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudoachondroplasia and multiple epiphyseal dysplasia: a 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution.
    Jackson GC; Mittaz-Crettol L; Taylor JA; Mortier GR; Spranger J; Zabel B; Le Merrer M; Cormier-Daire V; Hall CM; Offiah A; Wright MJ; Savarirayan R; Nishimura G; Ramsden SC; Elles R; Bonafe L; Superti-Furga A; Unger S; Zankl A; Briggs MD
    Hum Mutat; 2012 Jan; 33(1):144-57. PubMed ID: 21922596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in the known genes are not the major cause of MED; distinctive phenotypic entities among patients with no identified mutations.
    Jakkula E; Mäkitie O; Czarny-Ratajczak M; Jackson GC; Damignani R; Susic M; Briggs MD; Cole WG; Ala-Kokko L
    Eur J Hum Genet; 2005 Mar; 13(3):292-301. PubMed ID: 15523498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the Finnish founder mutation for diastrophic dysplasia (DTD).
    Hästbacka J; Kerrebrock A; Mokkala K; Clines G; Lovett M; Kaitila I; de la Chapelle A; Lander ES
    Eur J Hum Genet; 1999 Sep; 7(6):664-70. PubMed ID: 10482955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recessive multiple epiphyseal dysplasia - Clinical characteristics caused by rare compound heterozygous SLC26A2 genotypes.
    Kausar M; Mäkitie RE; Toiviainen-Salo S; Ignatius J; Anees M; Mäkitie O
    Eur J Med Genet; 2019 Nov; 62(11):103573. PubMed ID: 30423444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational biology insights into genotype-clinical phenotype-protein phenotype relationships between novel SLC26A2 variants identified in inherited skeletal dysplasias.
    Biji IK; Yadav S; Kulshrestha S; Saxena R; Kohli S; Verma IC; Kumar B; Puri RD
    Eur J Med Genet; 2022 Oct; 65(10):104595. PubMed ID: 36007841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping.
    Hästbacka J; de la Chapelle A; Mahtani MM; Clines G; Reeve-Daly MP; Daly M; Hamilton BA; Kusumi K; Trivedi B; Weaver A
    Cell; 1994 Sep; 78(6):1073-87. PubMed ID: 7923357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A family of chondrodysplasias caused by mutations in the diastrophic dysplasia sulfate transporter gene and associated with impaired sulfation of proteoglycans.
    Superti-Furga A; Hästbacka J; Rossi A; van der Harten JJ; Wilcox WR; Cohn DH; Rimoin DL; Steinmann B; Lander ES; Gitzelmann R
    Ann N Y Acad Sci; 1996 Jun; 785():195-201. PubMed ID: 8702127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.